Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban and Apixaban Therapy by Novel Automated Thrombelastography
Background: Direct-acting oral anticoagulants (DOACs) do not require monitoring. Measurement of DOAC effect would be useful in the event of bleeding, trauma, and thromboembolism while on anticoagulation. We evaluated the effectiveness of the investigational DOAC assays on the TEG®6s Hemostasis Analy...
Enregistré dans:
Auteurs principaux: | Ramin Artang, Joao Dias, Mark Walsh, Kevin P Bliden, Jørn Dalsgaard Nielsen, Maren Anderson, Brain Thurston, Udaya S. Tantry, Jan Hartmann, Paul A Gurbel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Georg Thieme Verlag KG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a579f2aee73f467a8bd1e62b2bbf4b46 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
par: Jana Úlehlová, et autres
Publié: (2021) -
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
par: Caroline Sindet-Pedersen, et autres
Publié: (2017) -
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
par: Frost C, et autres
Publié: (2014) -
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
par: Frost C, et autres
Publié: (2018) -
Anti-Xa Inhibitor-Induced Hemorrhagic Pruritic Rash: A Case Report on Possible Cross-Reactivity Between Apixaban and Rivaroxaban
par: Anis TR, et autres
Publié: (2021)